[
    {
        "molecule_name": "antigen-binding molecule",
        "protein_target_name": "inhibitory Fcγ receptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "1",
        "unit": "nM",
        "raw_mentions": "In some embodiments, the antigen-binding molecule comprising an Fc region as described herein binds to an inhibitory Fcγ receptor (e.g. hFcγRIIb mFcγRIIb) with a K<sub>D </sub>1 nM or greater, preferably one of ≥5 nM, ≥10 nM, ≥50 nM, ≥100 nM, ≥500 nM, ≥1000 nM, a 2000 nM, ≥3000 nM, ≥4000 nM or ≥5000 nM.\nIn some embodiments, the EC50 (ng/ml) determined for an antigen-binding molecule comprising an Fc region as described herein in an assay of ADCC activity less than 1 times, e.g. less than 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, or less than 0.1 times the EC50 (ng/ml) determined for an equivalent antigen-binding molecule having an Fc region comprised of CH2-CH3 having the amino acid sequence of SEQ ID NO:174-175.\nIn some embodiments, the EC50 (ng/ml) for an antigen-binding molecule comprising an Fc region as described herein in an assay of ADCC activity is 500 ng/ml or less, preferably one of ≤400 ng/ml, ≤300 ng/ml, ≤200 ng/ml, ≤100 ng/ml, ≤90 ng/ml, ≤80 ng/ml, ≤70 ng/ml, ≤60 ng/ml, ≤50 ng/ml, ≤40 ng/ml, ≤30 ng/ml, ≤20 ng/ml, or ≤10 ng/ml."
    },
    {
        "molecule_name": "Clone 10D1",
        "protein_target_name": "HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "9.58",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nClone 10D1 was found to bind to human HER3 with an affinity of K<sub>D</sub>=9.58 nM.\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c8972.6 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c90&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c91176 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_11B0.41 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o17.3 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c87&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c93&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c76&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c771.93 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c78&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c75&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c857.58 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o118.2 nM\nClone 4-35-B2 was found to bind to human HER3 with an affinity of K<sub>D</sub>=80.9 nM (FIG. 9), and clone 4-35-B4 was found to bind to human HER3 with an affinity of K<sub>D</sub>=50.3 nM (FIG. 10)."
    },
    {
        "molecule_name": "Clone 4-35-B2",
        "protein_target_name": "HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "80.9",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nClone 10D1 was found to bind to human HER3 with an affinity of K<sub>D</sub>=9.58 nM.\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c8972.6 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c90&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c91176 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_11B0.41 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o17.3 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c87&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c93&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c76&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c771.93 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c78&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c75&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c857.58 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o118.2 nM\nClone 4-35-B2 was found to bind to human HER3 with an affinity of K<sub>D</sub>=80.9 nM (FIG. 9), and clone 4-35-B4 was found to bind to human HER3 with an affinity of K<sub>D</sub>=50.3 nM (FIG. 10)."
    },
    {
        "molecule_name": "Clone 4-35-B4",
        "protein_target_name": "HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "50.3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nClone 10D1 was found to bind to human HER3 with an affinity of K<sub>D</sub>=9.58 nM.\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c8972.6 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c90&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c91176 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_11B0.41 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o17.3 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c87&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c93&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c76&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c771.93 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c78&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c75&lt;1 pM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c857.58 nM\nAntibody cloneAffinity (K<sub>D</sub>)10D1_c85o118.2 nM\nClone 4-35-B2 was found to bind to human HER3 with an affinity of K<sub>D</sub>=80.9 nM (FIG. 9), and clone 4-35-B4 was found to bind to human HER3 with an affinity of K<sub>D</sub>=50.3 nM (FIG. 10)."
    },
    {
        "molecule_name": "10D1F.FcA",
        "protein_target_name": "HER2:HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "IC50",
        "value": "lower",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\n10D1F.FcA was found inhibit HER2:HER3 dimerisation with greater efficiency than pertuzumab, as reflected by its lower IC50.\n\n\nNote that there is only one sentence that contains all four required components: a specific molecule name (10D1F.FcA and pertuzumab), a bioactivity metric (IC50), a specific numeric value for that metric (lower, but no exact value is given), and a unit for that value (not explicitly given). However, since the sentence implies a comparison of IC50 values, it can be inferred that the unit is likely to be a concentration unit such as nM or μM, but this is not explicitly stated.\n\n\nAfter re-reading the text, I found another sentence that could be relevant:\n\n\nCells were then treated with an 8-point serial dilution of 10D1F.FcA or Pertuzumab, starting from 25 μg/ml.\n\n\nThis sentence contains a specific molecule name (10D1F.FcA and Pertuzumab), a numeric value (25), and a unit (μg/ml), but it does not contain a bioactivity metric. Therefore, it does not meet the criteria.\n\n\nThe sentence:\n\n\nThe reaction was stopped with 2M H<sub>2</sub>SO<sub>4</sub>, and OD was measured at 450 nM.\n\n\ncontains a numeric value (450) and a unit (nM), but it does not contain a specific molecule name or a bioactivity metric. Therefore, it does not meet the criteria.\n\n\nThe sentence:\n\n\nBriefly, cell lines maintained in the indicated cell culture medium, supplemented with 10% FBS and 1% Pen/Strep.\n\n\ncontains a numeric value (10) and a unit (%), but it does not contain a specific molecule name or a bioactivity metric. Therefore, it does not meet the criteria.\n\n\nThe sentence:\n\n\nCells were cultured at 37° C., in 5% CO<sub>2 </sub>incubators.\n\n\ncontains a numeric value (5) and a unit (%), but it does not contain a specific molecule name or a bioactivity metric. Therefore, it does not meet the criteria.\n\n\nThe sentence:\n\n\n500,000 cells were stained in staining buffer containing 0.5% BSA and 2 mM EDTA with primary antibodies (20 μg/ml) for 1.5 h at 4° C.\n\n\ncontains numeric values (0.5, 2, 20) and units (% and μg/ml), but it does not contain a specific molecule name or a bioactivity metric. Therefore, it does not meet the criteria."
    },
    {
        "molecule_name": "10D1F.FcA",
        "protein_target_name": "HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "72.6",
        "unit": "μM",
        "raw_mentions": "10D1F.FcA binds to human HER3 with a high affinity of K<sub>D</sub>=72.6 μM (46A).\n10D1F.FcB binds to human HER3 with a high affinity of K<sub>D</sub>=22.2 μM (46B)."
    },
    {
        "molecule_name": "10D1F.FcB",
        "protein_target_name": "HER3",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "22.2",
        "unit": "μM",
        "raw_mentions": "10D1F.FcA binds to human HER3 with a high affinity of K<sub>D</sub>=72.6 μM (46A).\n10D1F.FcB binds to human HER3 with a high affinity of K<sub>D</sub>=22.2 μM (46B)."
    }
]